MBody AI Ltd. (MBAI) vs MedX Health Corp. (MDXHF)

MBody AI Ltd. and MedX Health Corp. are both Diagnostics & Research companies. MedX Health Corp. is the larger, with a market value of $103.2M against $69.0M — 1.5× the size. MBody AI Ltd. has the higher net margin (0.00% vs −1,095.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, MBody AI Ltd. leads on 7 and MedX Health Corp. on 5.

Valuation

Metric MBAI MDXHF Diagnostics & Research median
P/E n/m n/m 33.95
P/S n/m 25.16 4.87
P/B 1.02 n/m 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales n/m 30.65 5.66
Earnings yield (457.38%) (46.00%) (1.75%)
Free cash flow yield (338.71%) (55.11%) (0.13%)

Profitability

Metric MBAI MDXHF Diagnostics & Research median
Gross margin 0.00% (6.88%) 50.89%
Operating margin 0.00% (742.33%) (8.57%)
Net margin 0.00% (1,094.99%) (6.37%)
Free cash flow margin 0.00% (999.18%) 0.00%
Return on equity 0.00% 63.45% (2.92%)
Return on assets 0.00% (867.29%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MBAI MDXHF Diagnostics & Research median
Revenue growth (TTM) — 9.96% 7.69%
EPS growth (last fiscal year) 115.35% (52.00%) —
Revenue growth, 5-year CAGR — (55.05%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBAI MDXHF Diagnostics & Research median
Debt to equity 0.00 (0.32) 0.11
Current ratio 0.71 0.04 2.02
Net debt to EBITDA 0.09 (0.40) 0.78

Dividend

Metric MBAI MDXHF Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric MBAI MDXHF Diagnostics & Research median
Market cap 68.97m 103.16m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack